Terns Pharmaceuticals Inc
NASDAQ:TERN

Watchlist Manager
Terns Pharmaceuticals Inc Logo
Terns Pharmaceuticals Inc
NASDAQ:TERN
Watchlist
Price: 6.55 USD -3.39% Market Closed
Market Cap: 552.8m USD
Have any thoughts about
Terns Pharmaceuticals Inc?
Write Note

Terns Pharmaceuticals Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Terns Pharmaceuticals Inc
Total Equity Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Terns Pharmaceuticals Inc
NASDAQ:TERN
Total Equity
$255.4m
CAGR 3-Years
55%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Total Equity
$70.2B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
-1%
Bristol-Myers Squibb Co
NYSE:BMY
Total Equity
$17.1B
CAGR 3-Years
-23%
CAGR 5-Years
-1%
CAGR 10-Years
1%
Pfizer Inc
NYSE:PFE
Total Equity
$87.7B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
1%
Merck & Co Inc
NYSE:MRK
Total Equity
$44.5B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
0%
Eli Lilly and Co
NYSE:LLY
Total Equity
$14.2B
CAGR 3-Years
22%
CAGR 5-Years
33%
CAGR 10-Years
-2%

See Also

What is Terns Pharmaceuticals Inc's Total Equity?
Total Equity
255.4m USD

Based on the financial report for Dec 31, 2023, Terns Pharmaceuticals Inc's Total Equity amounts to 255.4m USD.

What is Terns Pharmaceuticals Inc's Total Equity growth rate?
Total Equity CAGR 5Y
29%

Over the last year, the Total Equity growth was -8%. The average annual Total Equity growth rates for Terns Pharmaceuticals Inc have been 55% over the past three years , 29% over the past five years .

Back to Top